We are committed to improving access to high quality medicines while working to ensure a reliable supply so patients can get the treatments they need, when and where they need them. Our global portfolio, supported by our science, medical and manufacturing expertise, delivers global iconic and key brands, generics - including complex and branded generics - and over-the-counter products.
We are committed to meaningfully reducing the burden of both noncommunicable and infectious diseases by leveraging our scientific, medical, manufacturing and commercial expertise to develop holistic, integrated solutions for diagnosis, prevention and treatment of these conditions.
Easing the burden of noncommunicable diseases
According to the World Health Organization (WHO), noncommunicable diseases (NCDs), such as ischemic heart disease, stroke, diabetes, certain cancers and chronic obstructive pulmonary disease, were among the leading causes of death globally as of 2016.1 NCDs affect people of every age, gender and socioeconomic status in every corner of the world, and pose a heavy burden on individuals, families and communities.
Fighting infectious disease
We are also a global leader in treating infectious diseases such as HIV/AIDS, hepatitis and tuberculosis, and offer an extensive portfolio across these disease states. From manufacturing a pediatric-friendly antiretroviral used to treat HIV-positive infants to providing HIV self-tests, we are innovating to help patients.